[
  {
    "ts": "2025-12-17T22:08:39+00:00",
    "headline": "Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review",
    "summary": "We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Bristol-Myers Squibb Company is one of the most undervalued stocks on our list. On Friday, December 12, 2025, TheFly reported that Guggenheim upgraded BMY’s stock rating from Neutral to Buy and set a new price target of $62, reflecting growing […]",
    "url": "https://finance.yahoo.com/news/guggenheim-sets-62-target-bristol-220839468.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0e4c6010-3b25-37a6-b8e4-2d00f63d27c1",
      "content": {
        "id": "0e4c6010-3b25-37a6-b8e4-2d00f63d27c1",
        "contentType": "STORY",
        "title": "Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review",
        "description": "",
        "summary": "We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Bristol-Myers Squibb Company is one of the most undervalued stocks on our list. On Friday, December 12, 2025, TheFly reported that Guggenheim upgraded BMY’s stock rating from Neutral to Buy and set a new price target of $62, reflecting growing […]",
        "pubDate": "2025-12-17T22:08:39Z",
        "displayTime": "2025-12-17T22:08:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f5d6c73ace872ad91d0b2c3c00cecec5",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2.soDmwXruEesj.zgCs1Mg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f5d6c73ace872ad91d0b2c3c00cecec5.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jjmQlIjO1hALZuhsFwsxnQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f5d6c73ace872ad91d0b2c3c00cecec5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/guggenheim-sets-62-target-bristol-220839468.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/guggenheim-sets-62-target-bristol-220839468.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T22:00:00+00:00",
    "headline": "These 2 Healthcare Stocks Just Declared Dividend Raises",
    "summary": "The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.",
    "url": "https://www.fool.com/investing/2025/12/17/healthcare-stocks-dividend-raise-bmy-zts/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c7424d05-2e8e-3e1b-891a-207f92386358",
      "content": {
        "id": "c7424d05-2e8e-3e1b-891a-207f92386358",
        "contentType": "STORY",
        "title": "These 2 Healthcare Stocks Just Declared Dividend Raises",
        "description": "",
        "summary": "The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.",
        "pubDate": "2025-12-17T22:00:00Z",
        "displayTime": "2025-12-17T22:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0212e5545c6b4b6c96283bcf9f86edfe",
          "originalWidth": 1400,
          "originalHeight": 935,
          "caption": "Person checking medicine on a shelf in a pharmacy.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MlM1XYXPd6cQLxijCfotlQ--~B/aD05MzU7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0212e5545c6b4b6c96283bcf9f86edfe.cf.webp",
              "width": 1400,
              "height": 935,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jCCIADCZa1xfK8EYeePPww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0212e5545c6b4b6c96283bcf9f86edfe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/17/healthcare-stocks-dividend-raise-bmy-zts/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-healthcare-stocks-just-declared-220000061.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T14:00:02+00:00",
    "headline": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-140002777.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "54dd8d80-69f3-3dd3-a223-7516e0080a91",
      "content": {
        "id": "54dd8d80-69f3-3dd3-a223-7516e0080a91",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2025-12-17T14:00:02Z",
        "displayTime": "2025-12-17T14:00:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VQTahvfxY5Qw8Ld_ibk8SA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uIfVIw8I.vo0_xUfE1XIrw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-140002777.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-140002777.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T11:34:48+00:00",
    "headline": "Harbour BioMed and BMS sign multi-specific antibody collab",
    "summary": "Harbour is eligible for payments of $90m, with potential development and commercial milestones of up to $1.035bn.",
    "url": "https://www.pharmaceutical-technology.com/news/harbour-biomed-bms/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "387efbcc-a1eb-334d-b68e-0626dc6b4ff0",
      "content": {
        "id": "387efbcc-a1eb-334d-b68e-0626dc6b4ff0",
        "contentType": "STORY",
        "title": "Harbour BioMed and BMS sign multi-specific antibody collab",
        "description": "",
        "summary": "Harbour is eligible for payments of $90m, with potential development and commercial milestones of up to $1.035bn.",
        "pubDate": "2025-12-17T11:34:48Z",
        "displayTime": "2025-12-17T11:34:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/5d8c827b869fab60ba0f6db5eecd4d2b",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Harbour BioMed will work alongside BMS to progress and expedite the programmes aimed at the discovery of multi-specific antibodies. Credit: shisu_ka/Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OP0DBPQhDHI_GwUZsZVvtg--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/5d8c827b869fab60ba0f6db5eecd4d2b.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sAPgQmOKfOvp7wAl.Av48A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/5d8c827b869fab60ba0f6db5eecd4d2b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/harbour-biomed-bms/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/harbour-biomed-bms-sign-multi-113448288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T00:04:00+00:00",
    "headline": "Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies",
    "summary": "Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generation multi-specific antibodies.",
    "url": "https://finance.yahoo.com/news/harbour-biomed-enters-global-strategic-000400663.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "32021510-1ee8-3c69-8b2d-abe7cb87c4ed",
      "content": {
        "id": "32021510-1ee8-3c69-8b2d-abe7cb87c4ed",
        "contentType": "STORY",
        "title": "Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies",
        "description": "",
        "summary": "Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generation multi-specific antibodies.",
        "pubDate": "2025-12-17T00:04:00Z",
        "displayTime": "2025-12-17T00:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/47f569ac406a18e992467aae42c1112a",
          "originalWidth": 400,
          "originalHeight": 159,
          "caption": "Logo (PRNewsfoto/Harbour BioMed)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eU3tZuceE0c3BXqaCVqYOA--~B/aD0xNTk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/47f569ac406a18e992467aae42c1112a.cf.webp",
              "width": 400,
              "height": 159,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/seB4VfNVt8dWdBv51mml1Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/47f569ac406a18e992467aae42c1112a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/harbour-biomed-enters-global-strategic-000400663.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/harbour-biomed-enters-global-strategic-000400663.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "HBMHF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]